Blog | Gen Re

Our Perspective

How Deep Brain Stimulation Helps Manage Neurological Disorders

By Dr. Chris Ball |October 24, 2017|English

Using electrical stimulation to manage brain disorders has a long and chequered history. Deep Brain Stimulation (DBS) is the latest. It involves implanting electrodes, connected to a computerized pulse generator, deep into the structure of the brain....
Read More
Are Functional Neurological Symptoms the “Great Deceivers”?

By Dr. Chris Ball |September 14, 2017|English

Neurological symptoms that lack an underlying structural abnormality cause significant distress and disability for those who experience them. Investigation and management consume large amounts of clinical resources. For insurers, neurological symptoms...
Read More
New Cancer Diagnostics - A Threat to Critical Illness Cover?

By Karin Brendel|August 28, 2017|English

A consensus among medical experts is that histopathology will lose its importance in selecting appropriate cancer treatment, and eventually diagnosis, over the course of the next 15 years. During this time, liquid biopsy techniques targeted at finding...
Read More
How Changes in Neurological Disorder Treatments Can Affect Claims

By Dr. Chris Ball |July 20, 2017|English

Brain disorders contribute significantly to disability figures throughout the world, adding more Disability-Adjusted Life Years than HIV or ischaemic heart disease. Many of these disorders have a young age of onset leading to long periods of disability...
Read More
Insurers Shouldn’t Stigmatize Epilepsy

By Anke Siebers |February 13, 2017|English | Deutsch

Epilepsy is a neurological disorder that can affect people of all ages. According to the WHO, some 50 million people around the world have epilepsy and an estimated 2.4 million new diagnoses are made each year. The condition has significant implications...
Read More
Breast Cancer in Asia – A Look at the Incidence Rates and Trends

By Dr. Himanshu Bhatia |November 28, 2016|English

Almost one in four cases of female breast cancer diagnoses around the world are in the Asia-Pacific region – the highest proportion of new cases in China (46%), Japan (14%) and Indonesia (12%). The global total of new cancer cases is projected...
Read More